World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT03361618
Date of registration: 07/11/2017
Prospective Registration: No
Primary sponsor: Babylon University
Public title: Effect of Oral Zinc Sulfate Supplementation on Enzymes of Urate Pathway
Scientific title: Effect of Oral Zinc Sulfate Supplementation on Enzymes of Urate Pathway in Spermatozoa and Seminal Plasma of Iraqi Asthenospermic Patients
Date of first enrolment: July 1, 2011
Target sample size: 120
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03361618
Study type:  Interventional
Study design:  Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Iraq
Contacts
Name:     Abdul Razzaq A. Alsalman, PhD
Address: 
Telephone:
Email:
Affiliation:  University of Babyblon
Name:     Lamia A. Almashhedy, PhD
Address: 
Telephone:
Email:
Affiliation:  University of Babyblon
Name:     Mahmoud Hussein Hadwan, PhD
Address: 
Telephone:
Email:
Affiliation:  University of Babyblon
Name:     Abdulsamie H Alta'ee, PhD
Address: 
Telephone:
Email:
Affiliation:  University of Babyblon
Key inclusion & exclusion criteria

Inclusion Criteria:

- The presence of asthenozoospermia in the semen sample.

- Must be unable to reproduce.

Exclusion Criteria:

- the absence of endocrinopathy, varicocele, and female factor infertility. Smokers and
alcoholic men were excluded from the study because of their recognized high seminal
ROS levels and decreased antioxidant levels.



Age minimum: 26 Years
Age maximum: 36 Years
Gender: Male
Health Condition(s) or Problem(s) studied
Infertility Unexplained
Intervention(s)
Dietary Supplement: Zinc Sulfate
Primary Outcome(s)
Measurement the uric acid level in spermatozoa and seminal plasma by using spectrophotometer. [Time Frame: up to three months.]
Secondary Outcome(s)
Measurement the xanthine oxidase activity in spermatozoa and seminal plasma by using spectrophotometer. [Time Frame: up to three months.]
Measurement the 5'-nucleotidase activity in spermatozoa and seminal plasmaby using the spectrophotometer. [Time Frame: up to three months.]
Measurement the adenosine deaminase activity in spermatozoa and seminal plasma by using spectrophotometer. [Time Frame: up to three months.]
Secondary ID(s)
Babil-5
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ministry of Health, Iraq
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history